A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Plaque Psoriasis in ChildrenPlaque Psoriasis in Adolescents

Interventions

DRUG

RSS0393 Ointment

RSS0393 ointment.

Trial Locations (1)

Beijing Children's Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY